Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference
August 31, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. Reports Second Quarter 2020 Financial Results
August 05, 2020 16:01 ET
|
Axogen, Inc.
ALACHUA, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
July 29, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., July 29, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects
July 22, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., July 22, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020
July 15, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., July 15, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
July 01, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced...
Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer
June 01, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference
May 20, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., May 20, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. Reports First Quarter 2020 Financial Results
May 06, 2020 16:01 ET
|
Axogen, Inc.
ALACHUA, Fla., May 06, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
Axogen, Inc. Reports Preliminary Revenue for the First Quarter 2020, Provides Business Update in Response to COVID-19 Pandemic, and Announces Dismissal of Class Action Lawsuit
April 23, 2020 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., April 23, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...